Vanguard Global Advisers’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Vanguard Global Advisers's TARS Position: Q3 2026 in Review
Vanguard Global Advisers reduced its Tarsus Pharmaceuticals (TARS) stake by 1.2% in Q3 2026, selling an estimated $12.4K and leaving 14,767 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1625.
Vanguard Global Advisers first reported a position in TARS in Q1 2026 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Vanguard Global Advisers held 14,767 shares of Tarsus Pharmaceuticals worth $1.16M as of Q3 2026.
- Vanguard Global Advisers sold 179 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $12.4K.
- Tarsus Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1625 holding.
- Vanguard Global Advisers first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.